Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Roger B. Cohen
Anti-Nkg2a mAb Is a Checkpoint Inhibitor That Promotes Anti-Tumor Immunity by Unleashing Both T and NK Cells
Cell
Biochemistry
Genetics
Molecular Biology
Research Participants' High Expectations of Benefit in Early-Phase Oncology Trials: Are We Asking the Right Question?
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Prospective Study of Proton-Beam Radiation Therapy for Limited-Stage Small Cell Lung Cancer
Cancer
Cancer Research
Oncology
Cisplatin Versus Cetuximab With Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: An Analysis of Veterans Health Affairs Data
Cancer
Cancer Research
Oncology
Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of Up to 8 Years of Treatment From the Abatacept Clinical Trial Program
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Erratum To: A Phase I Dose-Escalation Study of Selumetinib in Combination With Erlotinib or Temsirolimus in Patients With Advanced Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
A Phase I Dose-Escalation Study of Selumetinib in Combination With Docetaxel or Dacarbazine in Patients With Advanced Solid Tumors
BMC Cancer
Cancer Research
Oncology
Genetics
Cisplatin and Fluorouracil Alone or With Docetaxel in Head and Neck Cancer
New England Journal of Medicine
Medicine
